Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3215]

Immunotherapy agent benefits patients with drug-resistant multiple myeloma

Immunotherapy agent benefits patients with drug-resistant multiple myeloma

Building a better healthcare future through collaboration and technology

Building a better healthcare future through collaboration and technology

Genetic mutations may help predict risk of relapse, survival for leukaemia patients

Genetic mutations may help predict risk of relapse, survival for leukaemia patients

Live interactive debate: Latest in chronic lymphocytic leukaemia

Live interactive debate: Latest in chronic lymphocytic leukaemia

$European Medicines Agency accepts ixazomib’s marketing authorisation application for patients with relapsed/refractory multiple myeloma$

European Medicines Agency accepts ixazomib’s marketing authorisation application for patients with relapsed...

Genetic test could improve blood cancer treatment

Genetic test could improve blood cancer treatment

New treatment options for a fatal leukaemia

New treatment options for a fatal leukaemia

Apply for 3rd EurocanPlatform Summer School in Translational Cancer Research: Portugal, 12 – 16 October 2015

Apply for 3rd EurocanPlatform Summer School in Translational Cancer Research: Portugal, 12 – 16 October 2015

FDA approved sonidegib for locally advanced basal cell carcinoma

FDA approved sonidegib for locally advanced basal cell carcinoma

$European Medicines Agency grants accelerated assessment of ixazomib for patients with relapsed/refractory multiple myeloma$

European Medicines Agency grants accelerated assessment of ixazomib for patients with relapsed/refractory multiple...

More from ecancer